NVAX - NOVAVAX INC
10.8
0.110 1.019%
Share volume: 5,175,757
Last Updated: 03-11-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$10.69
0.11
0.01%
Summary score
41%
Profitability
25%
Dept financing
50%
Liquidity
45%
Performance
55%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2013 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
236.56%
Return on assets
-12.58%
Return on sales
0%
Return on invested capital
-130.9%
Total debt ratio
107.48%
Debt ratio change over timeo
0%
Current Ratio
4.09%
Quick Ratio
0%
Cash Position Ratio
2.08%
Short-term ratios 30-Sep-2016 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
328.97%
Return on assets
-12.28%
Return on sales
0%
Return on invested capital
-108.48%
Total debt ratio
112.06%
Debt ratio change over timeo
0%
Current Ratio
3.94%
Quick Ratio
0%
Cash Position Ratio
2.1%
Last quarter ratios 30-Sep-2017
The data are presented for the financials results of the last quarter.
Return on equity
60.16%
Return on assets
-12.46%
Return on sales
0%
Return on invested capital
-112.06%
Total debt ratio
122.2%
Debt ratio change over time
0%
Current Ratio
3.31%
Quick Ratio
0%
Cash Position Ratio
2%
Performance ratios (change over 4 years) 30-Sep-2013 - 30-Sep-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NVAX | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 236.56% | 6.52% | 16.07% | 8% |
| Return on assets | -12.58% | 3.2% | 7.46% | 5.12% |
| Return on sales | 0% | 44.03% | 59.59% | 42.46% |
| Return on invested capital | -130.9% | 9.05% | 13.06% | 8.23% |
| Profitability | 25% | 47% | 77% | 52% |
| Total debt ratio | 107.48% | 60.67% | 65.75% | 46.57% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 14% | 15% | 11% |
| Current Ratio | 3.94% | 5.2% | 2.96% | 2.29% |
| Quick Ratio | 0% | 4.88% | 2.8% | 1.99% |
| Cash Position Ratio | 2.1% | 0.33% | 1.09% | 0.45% |
| Liquididy | 46% | 54% | 38% | 31% |
| Short-term ratios | NVAX | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 328.97% | 6.57% | 13.54% | 7.21% |
| Return on assets | -12.28% | 3.23% | 6.63% | 5.05% |
| Return on sales | 0% | 44.59% | 57.77% | 41.29% |
| Return on invested capital | -108.48% | 9.41% | 12.01% | 7.62% |
| Profitability | 25% | 52% | 76% | 53% |
| Total debt ratio | 112.06% | 60.55% | 63.84% | 45.95% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 14% | 14% | 10% |
| Current Ratio | 3.94% | 5.2% | 2.96% | 2.29% |
| Quick Ratio | 0% | 4.88% | 2.8% | 1.99% |
| Cash Position Ratio | 2.1% | 0.33% | 1.09% | 0.45% |
| Liquididy | 44% | 54% | 42% | 27% |